• Citer

Ulceration and stage are predictive of interferon efficacy in melanoma: results of the phase III adjuvant trials EORTC 18952 and EORTC 18991.

par Eggermont, A;Suciu, Stefan ;Testori, Alessandro;Kruit, Wim H;Marsden, Jeremy;Punt, Cornelis;Santinami, M.;Sales, François ;Schadendorf, Dirk;Patel, Poulam;Dummer, Reinhard;Robert, Caroline;Keilholz, Ulrich;Yver, Antoine;Spatz, Alain
Référence European journal of cancer, 48, 2, page (218-225)
Publication Publié, 2012-01

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Ulceration and stage are predictive of interferon efficacy in melanoma: results of the phase III adjuvant trials EORTC 18952 and EORTC 18991.
Auteur:	Eggermont, A; Suciu, Stefan; Testori, Alessandro; Kruit, Wim H; Marsden, Jeremy; Punt, Cornelis; Santinami, M.; Sales, François; Schadendorf, Dirk; Patel, Poulam; Dummer, Reinhard; Robert, Caroline; Keilholz, Ulrich; Yver, Antoine; Spatz, Alain
Informations sur la publication:	European journal of cancer, 48, 2, page (218-225)
Statut de publication:	Publié, 2012-01
Sujet CREF:	Cancérologie
MeSH keywords:	Antineoplastic Agents -- therapeutic use
	Chemotherapy, Adjuvant
	Clinical Trials, Phase III as Topic
	Disease-Free Survival
	Epidemiologic Methods
	Female
	Humans
	Immunologic Factors -- administration & dosage
	Interferon-alpha -- administration & dosage
	Male
	Melanoma -- drug therapy -- mortality -- pathology
	Neoplasm Staging
	Polyethylene Glycols -- administration & dosage
	Predictive Value of Tests
	Randomized Controlled Trials as Topic
	Recombinant Proteins -- administration & dosage
	Skin Neoplasms -- drug therapy -- mortality -- pathology
	Ulcer -- pathology
Note générale:	Journal Article
	Meta-Analysis
	Research Support, Non-U.S. Gov't
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0959-8049
	info:doi/10.1016/j.ejca.2011.09.028
	info:pii/S0959-8049(11)00787-8
	info:scp/84655168007
	info:pmid/22056637